公开(公告)号：US20170340616A1

公开(公告)日：2017-11-30

申请号：US15673710

申请日：2017-08-10

Applicant: CHIESI FARMACEUTICI S.P.A.

Inventor： Elisabetta Armani ,  Gabriele Gabriele ,  Carmelida Capaldi ,  Wesley Blackaby ,  Ian Linney ,  Hervé Van De Poël ,  Charles Baker-Glenn ,  Naimisha Trivedi

IPC: A61K31/444 ,  C07D409/12 ,  A61K31/4436 ,  A61K31/4545 ,  C07D453/02 ,  C07D409/14

CPC classification number: A61K31/444 ,  A61K31/4436 ,  A61K31/4545 ,  C07D409/12 ,  C07D409/14 ,  C07D453/02

Abstract: Compounds of formula (I), defined herein, are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of a disease of the respiratory tract.